Cochrane News

Subscribe to Cochrane News feed
Updated: 5 hours 31 min ago

Making health decisions: what’s best for you? A free webinar on 20 Oct 2022

Thu, 09/15/2022 - 13:28

Join Cochrane UK for a free webinar for anyone making health decisions: Thursday 20th October 2022.

All of us have to make health decisions, whether that’s to seek advice about a condition, buying an over-the-counter treatment or health product off the shelf, whether to take up an invitation to screening, or perhaps having to make many decisions relating to a serious illness or long-term condition. 

Brian, Heather, and Sarah have all had some big health decisions to make, though in different circumstances. They will come together with Becky, a doctor and former GP who is used to taking part in discussions about health decisions in her everyday work, to talk about some important elements of making health choices.

We hope that the webinar will equip you with some questions and considerations that you can reflect on and discuss with a healthcare professional – to help you make the best health decision for you. There will be time for questions and answers, too.

Time and date: Thursday 20th October 2022, 7-8pm (BST). Check the time in your time zone.

Please register in advance for the webinar, which will take place on Zoom. After you've registered, you will receive information about how to join the webinar.

Read more about our panel HeatherBrianSarahBecky and our facilitators Rufaro and Emma.

This webinar is being held on World Evidence-Based Healthcare (EBHC) Day, an annual global initiative that raises awareness of the need for better evidence to inform healthcare policy, practice, and decision making in order to improve health outcomes globally. Cochrane is proud to be an official EBHC Day partner.

Thursday, September 15, 2022

Cochrane seeks Head of Communications - UK, remote

Mon, 09/12/2022 - 16:33

Specifications: Permanent
Salary: £60,000 per annum
Location: UK
Application Closing Date:  25 September 2022

Cochrane is a charity and a global, independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making vast amounts of research evidence useful for informing decisions about health. They do this by synthesising research findings to produce the best available evidence on what works. Their work has been recognised as the international gold standard for high quality, trusted information.



Cochrane is seeking an ambitious individual who relishes a challenge, loves collaborative working, delivers results and has extensive experience of successfully delivering strategy.  The role will be to lead and manage communications, in particular:

  • Developing a clear and robust communications strategy in support of our goals, and ensuring it is delivered to a high standard
  • To work across the organization significantly enhancing our internal and external communications.
  • Externally identifying opportunities to increase awareness of Cochrane.

Cochrane welcomes applications from a wide range of perspectives, experiences, locations and backgrounds; diversity, equity and inclusion are key to their values.

How to apply

  • For further information on the role and how to apply, please click here.  
  • The deadline to receive your application is by 25 September 2022. 
  • The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples. Note that we will assess applications as they are received, and therefore may fill the post before the deadline.
  • Read our Recruitment Privacy Statement
    Monday, September 12, 2022 Category: Jobs

    Cochrane Iberoamérica seeks Researcher/Systematic Reviewer and Project Manager - Barcelona, Spain

    Wed, 09/07/2022 - 14:00

    Cochrane is a global, independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesizing research findings to produce the best available evidence on what can work, what might harm, and where more research is needed. Our work is recognised as the international gold standard for high quality, trusted information.

    We have official geographic Cochrane Groups in 50+ countries. These Groups represent Cochrane in that country, promote, and support the use of Cochrane evidence in health policy and practice, and support Cochrane's members and supporters who live there.

    Cochrane Iberoamérica has two positions open at the Iberoamerican Cochrane Centre in Barcelona, Spain. 

    Researcher/Systematic Reviewer

    Project Manager

     

    Wednesday, September 7, 2022 Category: Jobs

    Covidence seeks Community Manager - North America, Remote

    Fri, 09/02/2022 - 17:12

    Specifications: Part time or full time (0.6-1 FTE)
    Salary range: USD$45,000-$55,000 (pro-rata as relevant)
    Closing date for applications: Friday, 30 September, 17:00 EDT

    Covidence is a standard author tool for Cochrane authors. Covidence online platform accelerates the production of systematic reviews. It helps systematic reviewers identify relevant research, appraise its quality, extract relevant data and prepare data ready for analysis. Covidence also helps users keep all their data in one place and enables remote teams to collaborate easily.

    Covidence is seeking a North America Community Manager. To excel as a Community Manager, you will have excellent interpersonal skills, strong written and verbal communication skills, and be highly organised with proven ability to appropriately prioritise tasks and deliver on time in a busy environment. You will have demonstrated capacity to work independently and with others in a globally distributed team. And importantly, you’ll have proven ability working with online technologies and social media.

     

    Friday, September 2, 2022 Category: Jobs

    Rho kinase inhibitors for primary open-angle glaucoma and ocular hypertension

    Fri, 09/02/2022 - 10:21
    Friday, September 2, 2022

    Music for insomnia in adults

    Wed, 08/31/2022 - 15:31
    Wednesday, August 31, 2022

    Liverpool School of Tropical Medicine seeks Professor/Senior Lecturer of Evidence Synthesis in Global Health - Liverpool, UK

    Tue, 08/30/2022 - 15:03

    Location: Liverpool, UK
    Contract type: Permanent / Full Time
    Closing date: Fri, Sep 30, 2022

    The Role:
    This leadership role is for a highly experienced scientist in evidence synthesis who will lead the further development of evidence synthesis, as part of the Global Health Trials and Synthesis Unit, and across the Liverpool School of Tropical Medicine and its partners.

    The Department of Clinical Sciences is a global leader in evidence synthesis providing an excellent platform for translational research from concept through discovery and clinical trials to evidence synthesis, teaching, policy change and eventual health impact. 

    Why join the department of clinical Sciences in this leadership post?
    The post arises with the retirement of the Director of the Evidence Synthesis in Global Health Centre. It provides a great opportunity for an academic with experience in the area to develop and shape their own portfolio of methods, reviews and collaborative links with researchers and policy personnel. There is an existing infrastructure, with high quality and experienced grant managers, search specialists, a statistician, and post-master staff, and has funds and programmes of work running to April 2024. 

    The Cochrane Infectious Diseases Group enabled pivotal reviews that led the evidence-base underpinning impregnated mosquito nets, artemisinin-based combination treatments, and a change in the formulation or oral rehydration salt solution. The work has been conducted as part of global collaboration within Cochrane and our own emerging evidence ecosystem. 

    Tuesday, August 30, 2022 Category: Jobs

    Cochrane joins the World Rehabilitation Alliance – come to the launch on 13 September

    Mon, 08/29/2022 - 12:50

    Around 2.4 billion people globally are estimated to live with a health condition that could benefit from rehabilitation. Yet despite this high need, many people around the world are currently unable to access appropriate services.

    Recognising this challenge, Cochrane has joined the World Rehabilitation Alliance (WRA), a World Health Organization (WHO) global network of stakeholders which aims to support the implementation of the Rehabilitation 2030 initiative by jointly advocating.

    Cochrane Rehabilitation will lead our involvement in the WRA, given the team’s longstanding work in this topic area, and will contribute primarily to the research workstream.

    Dr Carlotte Kiekens, Co-Director of Cochrane Rehabilitation, says:

    “In order to strengthen and upscale rehabilitation in health systems worldwide, it is of utmost importance that rehabilitation interventions are based on evidence. The best available evidence on rehabilitation must be available and accessible in appropriate formats to all who need it.”

    Cochrane Rehabilitation has collaborated with WHO to support the development of a robust evidence base to assist health policymakers for several years. They do this by providing synthesis and helping identify evidence gaps where high-quality research is needed. You can read more about their joint work in this interview with Cochrane Rehabilitation Director Professor Stefano Negrini.

    Join the launch event – Tuesday 13 September, 14:00-15:00 CET

    The WRA will formally launch during a virtual event on Tuesday 13 September. The event, which is free to attend and open to all, will introduce the WRA and why it has been established, and highlight some of the activities planned.

    Monday, August 29, 2022

    Antioxidants for male subfertility

    Fri, 08/26/2022 - 15:11
    Friday, August 26, 2022

    A new open access journal for Cochrane: Cochrane Evidence Synthesis and Methods

    Fri, 08/26/2022 - 14:47

    Cochrane’s first open access journal, Cochrane Evidence Synthesis and Methods, has opened for submissions! Working in conjunction with our publisher, Wiley, this journal strengthens Cochrane’s ability to meet our stakeholders’ needs and publish different types of evidence synthesis beyond systematic reviews. It will also include methods research evaluating how evidence syntheses is planned, produced and disseminated, and research articles on critical areas for evidence synthesis, such as, priority setting, consumer involvement, and research integrity.  

    Cochrane has over 100,000 members and contributors across an established global network who publish their systematic reviews in the Cochrane Database of Systematic Reviews. This new journal opens up opportunities for these members, and researchers new to Cochrane, to publish research outputs that go beyond Cochrane systematic reviews, which reflects the interests, talents and expertise of this global network and beyond. The journal aims to further develop the evidence base for how we produce and publish evidence synthesis, share best practice, case studies and commentaries.  

    Michael Brown, Editor, Cochrane Evidence Synthesis and Methods (responsible for the content and development of the journal), and Professor at Michigan State University, USA, explains, “The agility involved means we can collaborate more closely with guideline developers, decision makers and funders through publication of evidence syntheses directly relevant to their specific interests. We hope the community is as excited as we are to be able to publish this range of research relevant to evidence synthesis in a journal with Cochrane’s philosophy for transparency, integrity, and independence.”

    Karla Soares-Weiser, Editor-in-Chief, Cochrane, adds, “This is an exciting milestone for Cochrane as Cochrane Evidence Synthesis and Methods allows us to publish a wider range of evidence products that meets a more diverse range of stakeholder needs. It will enable Cochrane to better respond to important global health and social care needs and influence health decisions that go beyond the remit of systematic reviewing alone.”

    Ella Flemyng, Editorial Product Lead, Cochrane, explains why this new journal is important for the field, “Cochrane Evidence Synthesis and Methods welcomes innovative ideas and is not afraid to trial new ways of publishing. This includes showcasing practices that support research integrity, embedding consumer involvement within the journal, piloting how to better visualise research, and improving peer review - as a few examples.”

    For more information visit:

    Tuesday, November 15, 2022

    Cannabis and cannabinoids for people with multiple sclerosis

    Thu, 08/25/2022 - 14:58
    Thursday, August 25, 2022

    Running shoes for preventing lower‐limb running injuries in adults

    Mon, 08/22/2022 - 14:18
    Monday, August 22, 2022

    How systematic reviewers can bring attention to fraudulent studies, writes Lisa Bero in The Conversation US

    Fri, 08/19/2022 - 13:24

    While medical research is the best source of information on which to guide treatment of health issues, fraudulent studies are an issue. Such research can skew the evidence base and even lead to harm, as well as damage trust in the scientific process.

    Our Senior Research Integrity Editor, Lisa Bero, has recently written about this phenomenon in The Conversation US. In the article, she describes how systematic reviewers can be part of the solution and help to find such problematic studies. She also discusses research which she, Stephanie Boughton of the Cochrane Research Integrity team, and others have carried out about this.

    What is Cochrane doing about this issue?

    Cochrane has a policy in place that helps our reviewers spot problematic studies and decide what research to include and what to exclude in new reviews. When problems with medical research are so serious that the studies have to be withdrawn from publication, Cochrane also encourages our reviewers to go and back and mark where these studies have been included in reviews and, where necessary, update, amend or even withdrawn the review.

    Friday, August 19, 2022

    Pages